These data indicate, PLX5622 effectively depletes mature microglia and pro-inflammatory (CD86+) ones in the healthy and hydrocephalus neonatal brain, and mature (ApoE−) microglia are more sensitive to PLX5622-mediated microglial ablation. Here, CD86 is linked to Hydrocephalus.